ISIN | LU2488092722 |
---|---|
Valor Number | 119403767 |
Bloomberg Global ID | |
Fund Name | Kieger Sustainable Healthcare Fund Class B CHF Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
Peculiarities |
Current Price * | 96.58 CHF | 24.07.2025 |
---|---|---|
Previous Price * | 96.20 CHF | 23.07.2025 |
52 Week High * | 117.58 CHF | 02.09.2024 |
52 Week Low * | 93.48 CHF | 21.07.2025 |
NAV * | 96.58 CHF | 24.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 198,703,065 | |
Unit/Share Assets *** | 1,195,554 | |
Trading Information SIX |
YTD Performance | -10.97% |
31.12.2024 - 24.07.2025
31.12.2024 24.07.2025 |
---|---|---|
1 month | -1.00% |
24.06.2025 - 24.07.2025
24.06.2025 24.07.2025 |
3 months | -3.31% |
24.04.2025 - 24.07.2025
24.04.2025 24.07.2025 |
6 months | -16.17% |
24.01.2025 - 24.07.2025
24.01.2025 24.07.2025 |
1 year | -17.13% |
24.07.2024 - 24.07.2025
24.07.2024 24.07.2025 |
2 years | -5.40% |
24.07.2023 - 24.07.2025
24.07.2023 24.07.2025 |
3 years | -3.42% |
20.03.2023 - 24.07.2025
20.03.2023 24.07.2025 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 6.66% | |
---|---|---|
Abbott Laboratories | 5.64% | |
AstraZeneca PLC | 5.38% | |
Novartis AG Registered Shares | 5.33% | |
Roche Holding AG | 4.81% | |
UnitedHealth Group Inc | 4.61% | |
Boston Scientific Corp | 3.77% | |
Vertex Pharmaceuticals Inc | 3.66% | |
Intuitive Surgical Inc | 3.42% | |
Novo Nordisk AS Class B | 3.39% | |
Last data update | 30.04.2025 |
TER *** | 0.99% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |